Abiopharma

Xilio Therapeutics Appoints Akintunde Bello, Ph.D., to its Board of Directors

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BrightSpring Announces Secondary Offering of Common Stock

MIND TECHNOLOGY, INC. REPORTS FISCAL 2026 FIRST QUARTER RESULTS

BrightSpring Announces Secondary Offering of Common Stock

Voting Rights and Shares Capital of the Company

Celularity Announces Chief Financial Officer Transition

Celularity Announces Chief Financial Officer Transition

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alz